Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


03.04.2017

1 Am J Case Rep
1 Biophys J
1 Biosens Bioelectron
1 BMC Nephrol
1 Can Vet J
1 Cancer Cell
1 Cancer Epidemiol
1 Cancer Sci
1 Cancers (Basel)
1 Chem Commun (Camb)
4 Clin Genitourin Cancer
2 Diagn Cytopathol
1 Dis Markers
1 Eur Rev Med Pharmacol Sci
1 Expert Rev Anticancer Ther
1 Immunotherapy
1 In Vivo
1 Int J Mol Sci
1 J Huazhong Univ Sci Technolog Med Sci
1 J Laparoendosc Adv Surg Tech A
1 J Surg Oncol
1 Jpn J Clin Oncol
1 Med Mol Morphol
1 Nat Rev Urol
1 Oncoimmunology
1 Oncol Lett
1 Oncol Res
1 Pharm Dev Technol
1 PLoS One
1 PPAR Res
2 Pract Radiat Oncol
1 Ren Fail
1 Rofo
1 Sci Rep
1 Transl Oncol
2 Tumour Biol
1 Urol J
2 Urol Oncol
1 World J Surg Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Case Rep

  1. MD NOH MS, Abdul Aziz AF, Mohd Ghani KA, Lee Kheng Siang C, et al
    Giant Intradiverticular Bladder Tumor.
    Am J Case Rep. 2017;18:212-216.
    PubMed     Text format     Abstract available


    Biophys J

  2. SUNDAR RAJAN V, Laurent VM, Verdier C, Duperray A, et al
    Unraveling the Receptor-Ligand Interactions between Bladder Cancer Cells and the Endothelium Using AFM.
    Biophys J. 2017;112:1246-1257.
    PubMed     Text format     Abstract available


    Biosens Bioelectron

  3. LIU X, Wei M, Xu E, Yang H, et al
    A sensitive, label-free electrochemical detection of telomerase activity without modification or immobilization.
    Biosens Bioelectron. 2017;91:347-353.
    PubMed     Text format     Abstract available


    BMC Nephrol

  4. TSAI JL, Tsai SF
    Calcium oxalate crystal related kidney injury in a patient receiving Roux-en Y hepaticojejunostomy due to gall bladder cancer.
    BMC Nephrol. 2017;18:106.
    PubMed     Text format     Abstract available


    Can Vet J

  5. POLLARD RE, Watson KD, Hu X, Ingham E, et al
    Feasibility of quantitative contrast ultrasound imaging of bladder tumors in dogs.
    Can Vet J. 2017;58:70-72.
    PubMed     Text format     Abstract available


    Cancer Cell

  6. HEDEGAARD J, Lamy P, Nordentoft I, Algaba F, et al
    Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma.
    Cancer Cell. 2016;30:27-42.
    PubMed     Text format     Abstract available


    Cancer Epidemiol

  7. TURATI F, Bosetti C, Polesel J, Serraino D, et al
    Family history of cancer and the risk of bladder cancer: A case-control study from Italy.
    Cancer Epidemiol. 2017;48:29-35.
    PubMed     Text format     Abstract available


    Cancer Sci

  8. SATO A, Asano T, Okubo K, Isono M, et al
    Ritonavir and ixazomib kill bladder cancer cells by causing ubiquitinated protein accumulation.
    Cancer Sci. 2017 Mar 25. doi: 10.1111/cas.13242.
    PubMed     Text format     Abstract available


    Cancers (Basel)

  9. MOUW KW
    DNA Repair Pathway Alterations in Bladder Cancer.
    Cancers (Basel). 2017;9.
    PubMed     Text format     Abstract available


    Chem Commun (Camb)

  10. CHENG N, Xu Y, Luo Y, Zhu L, et al
    Specific and relative detection of urinary microRNA signatures in bladder cancer for point-of-care diagnostics.
    Chem Commun (Camb). 2017 Mar 30. doi: 10.1039/c7cc01007.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  11. SALAH S, Lee JL, Rozzi A, Kitamura H, et al
    Second-Line Chemotherapy for Metastatic Urothelial Carcinoma: Importance of Lymph Node-Only Metastasis as a Prognostic Factor and Construction of a Prognostic Model.
    Clin Genitourin Cancer. 2016;14:255-60.
    PubMed     Text format     Abstract available

  12. JAN AS, Dolan DE, Lombardi K, Gupta S, et al
    Tolerability of Gemcitabine Plus Cisplatin for Treatment of Urothelial Cancer in the Elderly Population.
    Clin Genitourin Cancer. 2016;14:e257-63.
    PubMed     Text format     Abstract available

  13. ANTONELLI A, Belotti S, Cristinelli L, De Luca V, et al
    Comparison of Perioperative Morbidity of Radical Cystectomy With Neobladder Versus Ileal Conduit: A Matched Pair Analysis of 170 Patients.
    Clin Genitourin Cancer. 2016;14:244-8.
    PubMed     Text format     Abstract available

  14. TAGUCHI S, Akamatsu N, Nakagawa T, Gonoi W, et al
    Sarcopenia Evaluated Using the Skeletal Muscle Index Is a Significant Prognostic Factor for Metastatic Urothelial Carcinoma.
    Clin Genitourin Cancer. 2016;14:237-43.
    PubMed     Text format     Abstract available


    Diagn Cytopathol

  15. LOBO J, Henrique R, Monteiro P, Lobo C, et al
    ALK-negative anaplastic large cell lymphoma with urinary bladder involvement diagnosed in urine cytology: A case report and literature review.
    Diagn Cytopathol. 2017;45:354-358.
    PubMed     Text format     Abstract available

  16. LEE J, Park S, Cho MS, Sung SH, et al
    Urine cytology findings of primary paraganglioma of the urinary bladder: Case report.
    Diagn Cytopathol. 2017;45:350-353.
    PubMed     Text format     Abstract available


    Dis Markers

  17. FINA E, Necchi A, Bottelli S, Reduzzi C, et al
    Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods.
    Dis Markers. 2017;2017:3414910.
    PubMed     Text format     Abstract available


    Eur Rev Med Pharmacol Sci

  18. MENG FM, Meng FM, Song XL
    MiR-576-3p is a novel marker correlated with poor clinical outcome in bladder cancer.
    Eur Rev Med Pharmacol Sci. 2017;21:973-977.
    PubMed     Text format     Abstract available


    Expert Rev Anticancer Ther

  19. WOLDU SL, Sanli O, Lotan Y
    Tackling Non-Muscle Invasive Bladder Cancer in the Clinic.
    Expert Rev Anticancer Ther. 2017 Mar 31. doi: 10.1080/14737140.2017.1313119.
    PubMed     Text format     Abstract available


    Immunotherapy

  20. AOUN F, Rassy EE, Assi T, Albisinni S, et al
    Advances in urothelial bladder cancer immunotherapy, dawn of a new age of treatment.
    Immunotherapy. 2017;9:451-460.
    PubMed     Text format     Abstract available


    In Vivo

  21. KASMANN L, Manig L, Janssen S, Rades D, et al
    Chemoradiation Including Paclitaxel for Locally Recurrent Muscle-invasive Bladder Cancer in Elderly Patients.
    In Vivo. 2017;31:239-241.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  22. LV M, Zhong Z, Chi H, Huang M, et al
    Genome-Wide Screen of miRNAs and Targeting mRNAs Reveals the Negatively Regulatory Effect of miR-130b-3p on PTEN by PI3K and Integrin beta1 Signaling Pathways in Bladder Carcinoma.
    Int J Mol Sci. 2016;18.
    PubMed     Text format     Abstract available


    J Huazhong Univ Sci Technolog Med Sci

  23. WANG ZY, Zhang W, Yang JJ, Song DK, et al
    Expression of miRNA-630 in bladder urothelial carcinoma and its clinical significance.
    J Huazhong Univ Sci Technolog Med Sci. 2016;36:705-709.
    PubMed     Text format     Abstract available


    J Laparoendosc Adv Surg Tech A

  24. SON SK, Lee NR, Kang SH, Lee SH, et al
    Safety and Effectiveness of Robot-Assisted Versus Open Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.
    J Laparoendosc Adv Surg Tech A. 2017 Mar 28. doi: 10.1089/lap.2016.0437.
    PubMed     Text format     Abstract available


    J Surg Oncol

  25. BROWN KG, Solomon MJ, Latif ER, Koh CE, et al
    Urological complications after cystectomy as part of pelvic exenteration are higher than that after cystectomy for primary bladder malignancy.
    J Surg Oncol. 2017;115:307-311.
    PubMed     Text format     Abstract available


    Jpn J Clin Oncol

  26. PANG C, Guan Y, Li H, Chen W, et al
    Urologic cancer in China.
    Jpn J Clin Oncol. 2016;46:497-501.
    PubMed     Text format     Abstract available


    Med Mol Morphol

  27. TAJIMA S, Suzuki T, Yamada Y, Morikawa T, et al
    Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.
    Med Mol Morphol. 2016;49:182-7.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  28. SIDAWAY P
    Bladder cancer: TCGA cohort is representative of invasive disease.
    Nat Rev Urol. 2017 Mar 29. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Oncoimmunology

  29. QU K, Gu J, Ye Y, Williams SB, et al
    High baseline levels of interleukin-8 in leukocytes and urine predict tumor recurrence in non-muscle invasive bladder cancer patients receiving bacillus Calmette-Guerin therapy: A long-term survival analysis.
    Oncoimmunology. 2017;6:e1265719.
    PubMed     Text format     Abstract available


    Oncol Lett

  30. WANG H, Zuo Y, Ding M, Ke C, et al
    LASS2 inhibits growth and invasion of bladder cancer by regulating ATPase activity.
    Oncol Lett. 2017;13:661-668.
    PubMed     Text format     Abstract available


    Oncol Res

  31. WANG R, Wu Y, Huang W, Chen W, et al
    MicroRNA-940 Targets INPP4A or GSK3beta and Activates the Wnt/beta-Catenin Pathway to Regulate the Malignant Behavior of Bladder Cancer Cells.
    Oncol Res. 2017 Mar 23. doi: 10.3727/096504017X14902261600566.
    PubMed     Text format     Abstract available


    Pharm Dev Technol

  32. OLIVEIRA MB, Villa Nova M, Bruschi ML
    A review of recent developments on micro/nanostructured pharmaceutical systems for intravesical therapy of the bladder cancer.
    Pharm Dev Technol. 2017 Mar 27:1-43. doi: 10.1080/10837450.2017.1312441.
    PubMed     Text format     Abstract available


    PLoS One

  33. IDE H, Inoue S, Miyamoto H
    Histopathological and prognostic significance of the expression of sex hormone receptors in bladder cancer: A meta-analysis of immunohistochemical studies.
    PLoS One. 2017;12:e0174746.
    PubMed     Text format     Abstract available


    PPAR Res

  34. CHIU M, McBeth L, Sindhwani P, Hinds TD, et al
    Deciphering the Roles of Thiazolidinediones and PPARgamma in Bladder Cancer.
    PPAR Res. 2017;2017:4810672.
    PubMed     Text format     Abstract available


    Pract Radiat Oncol

  35. KONG V, Kwan M, Chen S, Moseley J, et al
    Impact of image registration surrogates on the planning target volume geometry for bladder radiation therapy.
    Pract Radiat Oncol. 2016;6:e187-94.
    PubMed     Text format     Abstract available

  36. ISMAILI N
    External beam radiation therapy for small cell carcinoma of the bladder.
    Pract Radiat Oncol. 2016;6:e215-6.
    PubMed     Text format    


    Ren Fail

  37. CHO A, Lee SM, Noh JW, Choi DK, et al
    Acid-base disorders after orthotopic bladder replacement: comparison of an ileal neobladder and an ileal conduit.
    Ren Fail. 2017;39:379-384.
    PubMed     Text format     Abstract available


    Rofo

  38. SAUER M, Degen O, Beyersdorff D
    [Not Available].
    Rofo. 2016;188:782-3.
    PubMed     Text format    


    Sci Rep

  39. SEITZ AK, Christensen LL, Christensen E, Faarkrog K, et al
    Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.
    Sci Rep. 2017;7:395.
    PubMed     Text format     Abstract available


    Transl Oncol

  40. SIKIC D, Breyer J, Hartmann A, Burger M, et al
    High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer.
    Transl Oncol. 2017;10:340-345.
    PubMed     Text format     Abstract available


    Tumour Biol

  41. ZHANG H, Fan Y, Xia L, Gao C, et al
    The impact of advanced proteomics in the search for markers and therapeutic targets of bladder cancer.
    Tumour Biol. 2017;39:1010428317691183.
    PubMed     Text format     Abstract available

  42. VALE N, Gouveia MJ, Rinaldi G, Santos J, et al
    The role of estradiol metabolism in urogenital schistosomiasis-induced bladder cancer.
    Tumour Biol. 2017;39:1010428317692247.
    PubMed     Text format     Abstract available


    Urol J

  43. ISHIBASHI N, Maebayashi T, Aizawa T, Sakaguchi M, et al
    Refractory Haematuria Resulting From Peritoneal Dissemination of Metastatic Gastric Cancer: Radiation Therapy For A Nodule Infiltrating The Urinary Bladder.
    Urol J. 2017;14:2982-2984.
    PubMed     Text format     Abstract available


    Urol Oncol

  44. DONIN NM, Chamie K, Lenis AT, Pantuck AJ, et al
    A phase 2 study of TMX-101, intravesical imiquimod, for the treatment of carcinoma in situ bladder cancer.
    Urol Oncol. 2017;35:39.
    PubMed     Text format     Abstract available

  45. SORIA F, Lucca I, Moschini M, Mathieu R, et al
    Caveolin-1 as prognostic factor of disease recurrence and survival in patients treated with radical cystectomy for bladder cancer.
    Urol Oncol. 2017 Mar 22. pii: S1078-1439(17)30093.
    PubMed     Text format     Abstract available


    World J Surg Oncol

  46. ARAKAWA K, Ishihara S, Kawai K, Shibata J, et al
    Asynchronous bilateral anastomosis site sigmoid colon cancer after ureterosigmoidostomy: a case report.
    World J Surg Oncol. 2016;14:180.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: